Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
0(0%)
Results Posted
50%(6 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
4
31%
Ph not_applicable
1
8%
Ph phase_2
6
46%
Ph phase_3
2
15%

Phase Distribution

4

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
4(30.8%)
Phase 2Efficacy & side effects
6(46.2%)
Phase 3Large-scale testing
2(15.4%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(12)
Terminated(1)

Detailed Status

Completed12
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
92.3%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (30.8%)
Phase 26 (46.2%)
Phase 32 (15.4%)
N/A1 (7.7%)

Trials by Status

completed1292%
terminated18%

Recent Activity

0 active trials
Showing 5 of 13
completedphase_1

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

NCT00708604
completednot_applicable

Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

NCT01123187
completedphase_1

Allogeneic Islet Cells Transplanted Onto the Omentum

NCT02213003
completedphase_2

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

NCT02464878
completedphase_2

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

NCT00006505
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT00708604Phase 1

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

Completed
NCT01123187Not Applicable

Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

Completed
NCT02213003Phase 1

Allogeneic Islet Cells Transplanted Onto the Omentum

Completed
NCT02464878Phase 2

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

Completed
NCT00006505Phase 2

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

Completed
NCT00434811Phase 3

Islet Transplantation in Type 1 Diabetes

Completed
NCT00468117Phase 3

Efficacy of Islet After Kidney Transplantation

Completed
NCT00315627Phase 2

Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation

Completed
NCT00315588Phase 2

Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

Completed
NCT00014911Phase 2

Islet Transplantation for Type 1 Diabetes

Completed
NCT00453817Phase 1

Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging

Terminated
NCT00446264Phase 2

Islet Allotransplantation With Steroid Free Immunosuppression

Completed
NCT00073281Phase 1

Islet Transplantation for Patients With Type 1 Diabetes

Completed

All 13 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
13